Main description:

Ulcerative Colitis: The Complete Guide to Medical Management serves as the definitive source for medical management of ulcerative colitis (UC).

Dr. Gary R. Lichtenstein, along with Dr. Ellen J. Scherl, have collaborated with over 60 experts from around the world to provide gastroenterologists and those in training with the necessary information to successfully manage the patient with ulcerative colitis.

Sections Include:
* General
o The role of the FDA in drug development; pediatric considerations; disease modifiers; and more
* Medications
o Antibiotic use in treatment of UC; oral novel biological therapies for UC; calcineurin inhibitors use in UC; novel biologic and non-biologic therapy for UC; and more
* Specific Clinical Presentations
o Medical management of toxic megacolon; management of extraintestinal manifestations; medical therapy of left-sided UC; use of prebiotics and probiotics; maintenance of remission; and more

Features:
* Color images, graphs, and tables
* Extensive index that includes cross-referencing to Crohn's Disease: The Complete Guide to Medical Management
* Comprehensive references at the end of each chapter

Organized into an easy-to-reference format, Ulcerative Colitis: The Complete Guide to Medical Management threads theory into practice and provides gastroenterology professionals with the most comprehensive information available.

The other side of inflammatory bowel disease is covered in Drs. Gary R. Lichtenstein and Ellen J. Scherl's Crohn's Disease: The Complete Guide to Medical Management. All gastroenterologists will find both books to be essential for future practice in the treatment and care of their patients with either Crohn's disease or ulcerative colitis, as well as in the overall management of those with inflammatory bowel disease.

Contents:

DedicationAcknowledgmentsAbout the Editor and Associate EditorContributing AuthorsIntroduction Prologue Historical Perspective of Ulcerative Colitis Ming V. Lin, MD; Wojciech Blonski, MD, PhD; David Kotlyar, MD; and Gary R. Lichtenstein, MD,
FACP, FACG, AGAF Section I GeneralChapter 1 The Natural History of Inflammatory Bowel Disease Pietro G. Andres, MD and Lawrence S. Friedman, MDChapter 2 Clinical Research in Inflammatory Bowel Disease: Placebo Response in Clinical Trials Chinyu Su, MD and James D. Lewis, MD, MSCEChapter 3 The Role of the FDA in Drug Development in Inflammatory Bowel Disease Alan C. Moss, MD, FACG and Adam S. Cheifetz, MDChapter 4 Utility of Animal Models for the Study and Treatment of Inflammatory Bowel Disease Ashish Chawla, MD and Kenneth Simpson, BVM&S, PhDChapter 5 Pediatric Considerations in Medical Therapy in Patients With Inflammatory Bowel Disease Louis R. Ghanem, MD, PhD and Robert N. Baldassano, MD Chapter 6 The Limitations of Applying Evidence-Based Medicine to Inflammatory Bowel Disease: What We Do Not Learn From Clinical Trials Joshua R. Korzenik, MD and Corey A. Siegel, MDChapter 7 Disease Modifiers in Inflammatory Bowel Disease Jaime A. Oviedo, MD and Francis A. Farraye, MD, MSc, FACP, FACGChapter 8 Fertility and Pregnancy in Inflammatory Bowel Disease Jeffry A. Katz, MD and Vinita Elizabeth Jacob, MD Chapter 9 Diversion Colitis Eugeni Domenech, MD, PhD and Miguel A. Gassull, MD, PhD Chapter 10 Medication Adherence in Inflammatory Bowel Disease Sunanda V. Kane, MD, MSPH, FACG, FACP, AGAFSection II MedicationsChapter 11 General Principles of Medical Therapy of Ulcerative Colitis Sonia Friedman, MD, FACPChapter 12 Assessment of Disease Activity in Ulcerative Colitis Anthony L. Rosa, MD and Thomas A. Judge, MD Chapter 13 Current and Future Oral Mesalamine Derivative Use in Ulcerative Colitis Lloyd Sutherland, MDCM, MSc, FRCP(C), FACP Chapter 14 Current and Future Topical Mesalamine Derivatives in Ulcerative Colitis Jeffrey W. Nathanson, MD and Russell D. Cohen, MD Chapter 15 Antibiotics in Ulcerative Colitis Kim L. Isaacs, MD, PhDChapter 16 Oral and Parenteral Corticosteroids in Ulcerative Colitis Leonard Baidoo, MD and Gary R. Lichtenstein, MD, FACP, FACG, AGAFChapter 17 Topical Corticosteroid Use in Ulcerative Colitis Seymour Katz, MD, FACP, MACGChapter 18 6-Mercaptopurine and Azathioprine Use in Ulcerative Colitis Marla C. Dubinsky, MDChapter 19 Azathioprine Metabolism in Inflammatory Bowel Disease: A Physician's Guide to Metabolite Testing Carmen Cuffari, MD Chapter 20 Methotrexate in the Treatment of Ulcerative Colitis Ellen J. Scherl, MD, FACP, AGAF; Vinita Elizabeth Jacob, MD; Brian P. Bosworth, MD;
Ryan Urquhart Warren, MD; and Harrison Lakehomer, BA Chapter 21 Calcineurin Inhibitors (Cyclosporine, Tacrolimus, Sirolimus) and Mycophenolate Motefil Use in
Ulcerative Colitis Hans Herfarth, MD, PhD and Jurgen Schoelmerich, MD, PhDChapter 22 Infliximab Use in Ulcerative Colitis Wojciech Blonski, MD, PhD; Antoni Stadnicki, MD, PhD; Gary R. Lichtenstein, MD, FACP, FACG, AGAF; and Anne Burke, MDChapter 23 Other Tumor Necrosis Factor-Alpha Antagonists in Ulcerative Colitis Joshua R. Korzenik, MDChapter 24 Novel Biological Agents for the Treatment of Ulcerative Colitis Gert Van Assche, MD, PhD, FRCP and Paul Rutgeerts, MD, PhD, FRCPChapter 25 Novel Nonbiologic Therapy for Ulcerative Colitis William J. Sandborn, MDSection III........................................................................................... Specific ClinicalPresentationsChapter 26 Medical Management of Severe Ulcerative Colitis Niraj Jani, MD and Miguel Regueiro, MDChapter 27 Medical Management of Toxic Megacolon in the Patient with Ulcerative Colitis Robynne Chutkan, MD and Nabil Toubia, MDChapter 28 Medical Management of Ulcerative Proctitis Philip B. Miner Jr, MDChapter 29 Medical Therapy of Left-Sided Ulcerative Colitis Douglas B. Haghighi, DMD, MD and Bret A. Lashner, MD, MPHChapter 30 Management of Refractory Ulcerative Colitis Edward V. Loftus Jr, MD; Ellen J. Scherl, MD, FACP, AGAF; and Melissa H. Rosen, MDChapter 31 Pseudointractability of Inflammatory Bowel Disease Mansour A. Parsi, MD and Jean-Paul Achkar, MD Chapter 32 Medical Management of Extraintestinal Manifestations of Ulcerative Colitis Lloyd Mayer, MD and Robert Pittman, MDChapter 33 Nicotine and Inflammatory Bowel Disease Truc T. Trinh, MD; Richard S. Bloomfeld, MD, MS; and Stephen J. Bickston, MD, AGAFChapter 34 Management of Steroid-Refractory and Steroid-Dependent Severe Ulcerative Colitis Jesse A. Green, MD, FACG and Richard P. MacDermott, MD, FACGChapter 35 Prebiotics and Probiotics in Ulcerative Colitis Robert M. Penner, BSc, MD, FRCP(C), MSc; Karen L. Madsen, PhD; Massimo Campieri, MD;
and Richard N. Fedorak, MD, FRCP(C)Chapter 36 Management of Acute and Chronic Pouchitis James M. Becker, MD, FACS and Arthur F. Stucchi, PhDChapter 37 Dietary Manipulations: Oral and Enteral Nutritional Therapy for Ulcerative Colitis Traci M. Temmen, MD and John L. Rombeau, MDChapter 38 Parenteral Nutrition Use in Ulcerative Colitis Alan L. Buchman, MD, MSPHChapter 39 Maintenance of Remission in Ulcerative Colitis Kenneth W. Schroeder, MD, PhD and William J. Tremaine, MDFinancial Disclosures Index